Treatment of haemophilia in the United Kingdom 1981-1996
- 12 July 2001
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 7 (4), 349-359
- https://doi.org/10.1046/j.1365-2516.2001.00521.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia populationThe Lancet, 1996
- Mortality before and after HIV infection in the complete UK population of haemophiliacsNature, 1995
- The incidence of factor VIII inhibitors in the United Kingdom, 1990‐93British Journal of Haematology, 1995
- Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): a report on behalf of U.K. Haemophilia Centre DirectorsBritish Journal of Haematology, 1993
- Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand??s diseaseBlood Coagulation & Fibrinolysis, 1992
- Carrier testing and prenatal diagnosis for hemophilia: Experiences and attitudes of 549 potential and obligate carriersAmerican Journal of Medical Genetics, 1990
- HIV Seroconversion in Haemophilic Boys Receiving Heat‐Treated Factor VIII ConcentrateVox Sanguinis, 1990
- Seropositivity for HIV in U.K. haemophiliacsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1989
- Gene deletions in patients with haemophilia B and anti-factor IX antibodiesNature, 1983
- Jaundice and Antibodies Directed against Factors VIII and IX in Patients Treated for Haemophilia or Christmas Disease in the United KingdomBritish Journal of Haematology, 1974